The following article is a comprehensive update to our article from September 2012 "Time To Buy DARA Bio," which recommended purchase of DARA Biosciences (DARA) at $0.86 per share. Since that original call, DARA has traded to a high of $1.38 to a low of $0.52. At today's price of $0.57, we're down 33% on this call. Although we're disappointed in this performance, we believe ultimately patience will be rewarded by owning the stock.
Business & Financial Update
On August 15, 2013, DARA Biosciences reported financial results for the second quarter 2013. Total revenues in the quarter were $76,936, an admittedly low absolute number but up nicely from the $21,180 reported in the first quarter...
Only subscribers can access this article, which is part of the PRO research library covering 3,591 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: